Efficacy and safety of methylphenidate on attention deficit hyperactivity disorder in children with Down syndrome

Down Syndrome ◽

Attention Deficit ◽

Efficacy And Safety ◽

Guanfacine Use in Children With Down Syndrome and Comorbid Attention-Deficit Hyperactivity Disorder (ADHD) With Disruptive Behaviors

Journal of Child Neurology ◽

10.1177/0883073816634854 ◽

2016 ◽

Vol 31 (8) ◽

pp. 957-964 ◽

Cited By ~ 9

Author(s):

George T. Capone ◽

Liza Brecher ◽

Mihee Bay

Keyword(s):

Down Syndrome ◽

Attention Deficit ◽

Disruptive Behaviors ◽

Adaptive and Behavioral Development in Children with Down Syndrome at School Age with Special Emphasis on Attention Deficit Hyperactivity Disorder (ADHD)

Prenatal Diagnosis and Screening for Down Syndrome ◽

10.5772/17455 ◽

2011 ◽

Cited By ~ 1

Author(s):

Asher Ornoy ◽

Tanya Rihtman ◽

Shula Parush

Keyword(s):

Down Syndrome ◽

Attention Deficit ◽

Behavioral Development ◽

School Age ◽

Comparison of Attention-Deficit Hyperactivity Disorder in Typically Developing Children and Children with Down Syndrome

Journal of Developmental & Behavioral Pediatrics ◽

10.1097/dbp.0000000000000972 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Anna J. Esbensen ◽

Jeffery N. Epstein ◽

Lori B. Vincent ◽

Kelly Kamimura-Nishimura ◽

Susan Wiley ◽

...

Keyword(s):

Down Syndrome ◽

Attention Deficit ◽

Typically Developing ◽

Typically Developing Children ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

CNS Drugs ◽

10.1007/s40263-013-0104-8 ◽

2013 ◽

Vol 27 (12) ◽

pp. 1081-1092 ◽

Cited By ~ 53

Author(s):

Ralf W. Dittmann ◽

Esther Cardo ◽

Peter Nagy ◽

Colleen S. Anderson ◽

Ralph Bloomfield ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Hyperactivity Disorder ◽

Phase Iiib

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents

Archives of Clinical Psychiatry (São Paulo) ◽

10.1590/0101-60830000000007 ◽

2014 ◽

Vol 41 (2) ◽

pp. 34-39 ◽

Cited By ~ 2

Author(s):

Paulo Mattos

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2011.01.007 ◽

2011 ◽

Vol 50 (4) ◽

pp. 395-405 ◽

Cited By ~ 72

Author(s):

Robert L. Findling ◽

Ann C. Childress ◽

Andrew J. Cutler ◽

Maria Gasior ◽

Mohamed Hamdani ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2009.0106 ◽

2010 ◽

Vol 20 (5) ◽

pp. 377-385 ◽

Cited By ~ 9

Author(s):

Eberhard Schulz ◽

Christian Fleischhaker ◽

Klaus Hennighausen ◽

Philip Heiser ◽

Klaus-Uwe Oehler ◽

...

Keyword(s):

Attention Deficit ◽

Classroom Setting ◽

Efficacy And Safety ◽

Double Blind ◽

Hyperactivity Disorder ◽

Laboratory Classroom

Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

Journal of Clinical Psychopharmacology ◽

10.1097/jcp.0b013e3181a390ce ◽

2009 ◽

Vol 29 (3) ◽

pp. 239-247 ◽

Cited By ~ 73

Author(s):

Lenard A. Adler ◽

Brenda Zimmerman ◽

H. Lynn Starr ◽

Steve Silber ◽

Joseph Palumbo ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release